Old Web
English
Sign In
Acemap
>
authorDetail
>
A. Valle Díaz de la Guardia
A. Valle Díaz de la Guardia
Intensive care medicine
Medicine
Pharmacy
Standard treatment
Adverse effect
5
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
OHP-019 Budget impact of fingolimod in the treatment of multiple sclerosis
2015
European Journal of Hospital Pharmacy-Science and Practice
R. Morón
A. Valle Díaz de la Guardia
C. Gonzalez
J. Cabeza
Show All
Source
Cite
Save
Citations (0)
GRP-180 Telaprevir and Boceprevir: Safety and Efficacy of the Initial Treatments in the Hospital
2013
European Journal of Hospital Pharmacy-Science and Practice
A. Valle Díaz de la Guardia
C García Fernández
C Gómez-Peña
J Cabeza Barrera
Show All
Source
Cite
Save
Citations (0)
Prevalence and spectrum of chronic kidney disease in HIV-positive patients
2012
European Journal of Hospital Pharmacy-Science and Practice
S Belda Rustarazo
S. Ruiz Fuente
S Cortés de Miguel
C. Fernandez Lopez
C Medarde-Caballero
J Cabeza Barrera
A. Valle Díaz de la Guardia
Show All
Source
Cite
Save
Citations (1)
Detection of drug interactions between protease inhibitors and prescribed treatment in primary care
2012
European Journal of Hospital Pharmacy-Science and Practice
A. Valle Díaz de la Guardia
E Espinola-Garcia
M. A. García-Lirola
C Medarde-Caballero
C. Fernandez Lopez
Show All
Source
Cite
Save
Citations (0)
Simplification of ARV treatment with lopinavir/ritonavir: clinical assessment and financial impact
2012
European Journal of Hospital Pharmacy-Science and Practice
A. Valle Díaz de la Guardia
C Medarde-Caballero
C. Fernandez Lopez
J Cabeza Barrera
Show All
Source
Cite
Save
Citations (0)
1